From: A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer
Gene Symbol | Fold-change CRC vs. NT | CRC line | Oxa | 5-FU | Cpt | Lova | Oxa + Lova | 5-FU + Lova | Cpt + Lova |
---|---|---|---|---|---|---|---|---|---|
CHECK2 | 2.08*** | HCT-116 | NC | 0.69* | NC | NC | 0.56*** | 0.44** | NC |
HT-29 | 2.74* | 2.43 | 1.40* | 0.51* | 2.60* | 1.84* | 2.33** | ||
CYP51A1 | 2.80*** | HCT-116 | NC | 0.44* | 0.31* | NC | 0.56** | 0.22** | (0.64) |
CYP11A1 | 0.32** | HCT-116 | NC | NC | NC | NC | 0.53* | 0.78** | NC |
BCL2 | 0.31*** | HCT-116 | 0.23*** | 0.46* | 0.52* | NC | 0.14*** | 0.17*** | 0.61** |
NME1 | 4.6*** | HCT-116 | 2.72*** | NC | NC | NC | 0.60** | 0.30** | 0.52* |
HT-29 | 1.81* | NC | NC | 0.52* | NC | (0.61) | NC | ||
ITGA2 | 3.8*** | HCT-116 | 1.77** | NC | NC | NC | 0.68* | 0.35* | NC |
HT-29 | NC | NC | (0.41) | 0.38* | 0.50** | (0.51) | 0.47** | ||
IL8 | 8.1** | HCT-116 | 3.35*** | NC | NC | NC | (3.87) | 3.37* | (3.01) |
HT-29 | 2.92* | 4.74* | 2.33* | 0.64*** | 3.24* | 3.81* | 3.52*** | ||
NOS3 | 2.3*** | HCT-116 | 1.87** | 1.63*** | NC | NC | NC | 2.13* | NC |
HT-29 | NC | 3.42** | NC | 0.56** | NC | 1.97* | (2.16) | ||
DHCR7 | 3.6*** | HCT-116 | NC | NC | 0.48* | NC | NC | NC | 0.49** |
HT-29 | NC | NC | NC | NC | 1.50* | 2.29*** | NC | ||
HMGCS1 | 2.46*** | HCT-116 | 0.82* | 0.46** | 0.23*** | NC | NC | NC | 0.32* |
HT-29 | NC | 0.37** | 0.42* | NC | NC | NC | NC | ||
VEGFA | 2.04*** | HT-29 | NC | NC | NC | 0.43** | NC | 0.54* | NC |